30/09/20 9:15amZelira ZLD Signs Real-World Data Agreement for...

30/09/20 9:15am
Zelira ZLD Signs Real-World Data Agreement for Insomnia Drug Zenivol™ with Emyria30 September 2020• Leverages Emyria’s clinical and data expertise to monitor the safety and efficacy of Zenivol™treatment in patients diagnosed with chronic insomnia • Real-world data will complement existing clinical data for Zenivol™ and inform path to further development and product registration• Data will add further value to the global commercialisation opportunities for Zenivol™• Partnership reinforces Zelira’s competitive advantage for bringing high-value cannabinoid medicines to market supported by clinical and real-world patient data